Clinical Evidence for GLP-1 Injections During Ramadan The use of GLP-1 receptor agonists during Ramadan has been the subject of growing clinical research, particularly because these medications were originally developed for type 2 diabetes management
GLP-1 also slows down gastric emptying, which can help to reduce appetite and promote feelings of fullness
Semaglutide works by mimicking the effects the hormone glucagon-like peptide-1 (GLP-1)
Understanding how Mounjaro works, what the research shows, and what results are realistically achievable is essential for safe decision-making
Factors that can influence individual responses include: Preexisting Mental Health Conditions : People with a history of depression, anxiety, or bipolar disorder may be more sensitive to mood changes caused by medications
That matches the broader pattern: some adverse events only emerge at scale in Phase 3 populations treated for longer periods